A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, ...

Looking to block out the sun and add a stylish touch to your home? In this Home Zone project, we’re tackling window coverings ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

As the cold winter weather sets in, keeping your home warm and energy-efficient becomes a top priority. One of the biggest ...

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

Lutron has announced its new Caséta Smart Shades, a cheaper alternative to the company’s more premium options in the past.

Lutron has earned a reputation for high-quality HomeKit-compatible window blinds, but with a very hefty price tag. The cost ...

Lutron launches Caséta smart shades with DIY installation and smart home integration. Quiet, customizable, and affordable for ...

Lutron Electronics, a leader in lighting control and automated shading solutions, has again raised the bar by introducing the new Caséta smart shades at CES 2025. I got a sneak peek at these new smart ...

I never thought a blind date would include flying thousands of miles with someone to see whether we were compatible, but when mutual friends set me up, I couldn't resist. My date was in the Air ...